Skip to content

These 3 Biotech Stocks May Be The Best Pure Plays On Two Remarkable Advances In Cancer Treatment

A number of conferences have recently taken place where cancer researchers have revealed the latest and most promising developments in the fight against this disease. Today’s article highlights critical advances in two existing cancer therapies – one which allows the immune system to find otherwise invisible tumors and another in which the white blood cells of blood cancer patients are genetically altered so they can better fight the disease – as well as three biotech companies that the author sees as the best pure plays on these advances for investors. To read more, CLICK HERE.